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ABSTRACT
The impact of 2’-deoxy-2’-fluoroarabinonucleotide
residues (2’F-araN) on different G-quadruplexes
derived from a thrombin-binding DNA aptamer
d(G2T2G2TGTG2T2G2), an anti-HIV phosphorothioate
aptamer PS-d(T2G4T2) and a DNA telomeric
sequence d(G4T4G4) via UV thermal melting (Tm)
and circular dichroism (CD) experiments has been
investigated. Generally, replacement of deoxygua-
nosines that adopt the anti conformation (anti-
guanines) with 2’F-araG can stabilize G-quartets
and maintain the quadruplex conformation, while
replacement of syn-guanines with 2’F-araG is not
favored and results in a dramatic switch to an
alternative quadruplex conformation. It was found
that incorporation of 2’F-araG or T residues into a
thrombin-binding DNA G-quadruplex stabilizes the
complex ("Tm up to »+38C/2’F-araN modification);
2’F-araN units also increased the half-life in 10%
fetal bovine serum (FBS) up to 48-fold. Two modified
thrombin-binding aptamers (PG13 and PG14) show
an approximately 4-fold increase in binding affinity
to thrombin, as assessed via a nitrocellulose
filter binding assay, both with increased thermal
stability (»18C/2’F-ANA modification increase in Tm)
and nuclease resistance (4–7-fold) as well.
Therefore, the 2’-deoxy-2’-fluoro-D-arabinonucleic
acid (2’F-ANA) modification is well suited to tune
(and improve) the physicochemical and biological
properties of naturally occurring DNA G-quartets.
INTRODUCTION
Guanine quartet (G-quartet) structures with four
Hoogsteen-paired, coplanar guanines were ﬁrst observed
more than 40 years ago (1) and later demonstrated to be a
unique structural motif of guanine-rich oligonucleotides
(2) (Figure 1A). G-quartets are found in nature and also
in sequences identiﬁed by screening techniques such
as Systematic Evolution of Ligands by EXponential
enrichment (SELEX) (3–5). They have also aroused
interest as therapeutic agents to inhibit human thrombin
(6,7), HIV infection (7–9), and as targets themselves to
inhibit telomerase activity in anticancer drug design (10).
G-quartets display extraordinary structural poly-
morphism (11–13). The 15-nt DNA sequence
d(G2T2G2TGTG2T2G2) (6) binds and inactivate throm-
bin, a key enzyme in the blood clotting cascade. NMR
spectroscopy reveals that it adopts a uniquely folded
structure with two stacked G-quartets connected through
edge-loops (one TGT and two TT loops) involving
antiparallel alignment of adjacent strands (Figure 1B)
(14–17). A seemly diﬀerent crystal structure of this
aptamer–thrombin complex (18,19) was later analyzed to
be in agreement with the previous NMR structure (19,20).
Potassium ions stabilize the G-quadruplex by coordina-
tion to the G residues (15). The G-quartet displays an
alternating syn and anti conformation of guanine bases
(syn- and anti-Gs) on the same plane and 50-syn-G/30-anti-
G along each strand of the quadruplex (i.e. 50-syn-anti-30
connectivity where syn-G includes G1, G5, G10 and G14
and anti-G includes G2, G6, G11 and G15 in Figure 1B)
and all the thymidines are in the anti orientation (15).
The telomeric sequence d(G4T4G4) adopts symmetrical
dimeric quadruplexes comprising four G-quartets linked
through a diagonal loop as analyzed by NMR in sodium
(Na
+) environment (Figure 1C) (21,22) or an edge-loop
structure as revealed by X-crystallography in potassium
(K
+) environment (23). More recent studies re-examined
the crystal structure of this sequence and suggested the
crystal structure also adopts a diagonal conformation,
consistent with the NMR solution structure (24). The
diagonal loop conﬁguration (Figure 1C) consists of
50-syn-G/30-anti-G along each G-strand, syn-syn-anti-anti
conformations in a G-quartet and all sugar residues
puckered in the south (C20-endo) conformation (22,25).
Another interesting example is the phosphorothioate
oligonucleotide PS-d(T2G4T2) identiﬁed as an inhibitor
of HIV-1 infection in vitro by combinatorial screening of
a library of DNA strands. This aptamer inhibits HIV
envelope-mediated cell fusion in vitro and its structure
consists of a parallel-stranded tetramer with all guanines
in the anti-conformation (Figure 1D) (2,7).
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of guanines (i.e. syn- and anti-Gs) have a strong
correlation with strand alignments. Parallel-stranded
quadruplexes (Figure 1D) support only anti-G residues,
while antiparallel-stranded quadruplexes favor alternating
syn-anti Gs engaged in unimolecular (Figure 1B) or
intermolecular complexes (Figure 1C) (11,26).
G-quadruplexes are sensitive to chemical modiﬁcations.
Several studies aimed at modifying the thrombin-binding
aptamer d(G2T2G2TGTG2T2G2) have been reported
(27–31), but very few, if any, have led to an improvement
over the original molecule. For example, Seela and
coworkers recently reported the insertion of a hairpin-
forming sequence GCGAAG into the position of the
central loop (TGT) of the thrombin-binding aptamer. This
construct formed a G-quadruplex fused to a mini-hairpin
structure. According to the Tm data, the mini-hairpin
induces a structural change in the aptamer section, leading
to less stable G-quadruplex. Binding to thrombin was
not investigated (30). Sacca ` et al. studied the eﬀect of
backbone charge and atom size, base substitutions as well
as the eﬀect of modiﬁcation at the sugar 20-position as
analyzed by spectroscopy. Fully modiﬁed aptamers with
sugar modiﬁcations (ribose, 20-O-methylribose) and
phosphate backbone modiﬁcations (methylphosphonate,
phosphorothioate) led to a reduction in the thermal
stability (31). In fact, the 20-O-methylribose modiﬁcation
led not only to a destabilization of the structure but to a
complete transformation of the G-tetrad conformation,
as shown by spectroscopy in potassium buﬀer (31).
20-O-methylribose was also shown to causes structural
changes in RNA aptamers and often resulted in a loss of
activity (32). Accordingly, there is a need for new chemical
modiﬁcations to improve the nuclease stability of this and
other aptamers. Ideally, these modiﬁcations will not alter
the subtle binding interactions of the selected native
aptamers and the thermal stability of G-quadruplexes.
20-Deoxy-20-ﬂuoro-D-arabinonucleic acids (20F-ANA)
confer DNA-like (South/East) conformations (33) to
oligonucleotides while rendering them more nuclease
resistant (34). The incorporation of 20F-araN units in
oligonucleotides also raises the Tm of diﬀerent systems, i.e.
duplexes ( +18C/nt) (35), triplexes ( +0.88C/nt) (36)
and C-rich quadruplexes ( +18C/nt, pH 54.0) (37).
In light of this and other advantageous characteristics of
2F-ANA, such as synthetic accessibility through
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Figure 1. Structure of (A) G-quartet with cyclic array of four guanines linked by Hoogsteen H-bonds (1); (B) thrombin-binding DNA
d(G2T2G2TGTG2T2G2) with an edge-loop (chair-like) unimolecular G-quadruplex in K
+ (15,16); (C) a telomeric DNA d(G4T4G4) with diagonal-
loop dimeric hairpin complex [d(G4T4G4)]2 in Na
+ (21,22); (D) a tetrameric G-quadruplex [d(PS-T2G4T2)]4 with four parallel strands (2,7).
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promising antisense/siRNA properties (34,38–40), we
have undertaken the ﬁrst study concerning the ability of
20F-ANA to form various G-quadruplex structures as
analyzed by Tm and CD experiments. 20F-ANA modiﬁed
thrombin-binding aptamers were further evaluated by
their nuclease resistance and binding aﬃnity to thrombin.
The outcome of these studies has opened new perspec-
tives for the application of 20F-ANA as aptamer
oligonucleotides.
MATERIALS AND METHODS
Chemical synthesis ofoligonucleotides
The sequence and composition of the oligomers prepared
in this study are shown in Tables 1 and 2. Arabinose
modiﬁed aptamer syntheses were carried out at a 1mmol
scale on an Applied Biosystems (ABI) 3400A syn-
thesizer using standard b-cyanoethylphosphoramidite
chemistry according to published protocols (41).
Deoxyribonucleoside phosphoramidites were purchased
from ChemGenes (Waltham, MA) and 20F-
arabinonucleoside 30-O-phosphoramidites were provided
by Topigen Pharmaceuticals Inc. (Montreal, Canada).
The ﬁnal concentrations of the monomers were 0.10M for
20-deoxyribonucleoside phosphoramidites and 0.125M
for the 20F-arabinose phosphoramidites. The coupling
time was extended to 150s for the 20-deoxyribonucleoside
phosphoramidites dC and dG, and 15min for the
20F-araG and T phosphoramidites. These conditions
gave about 99% average stepwise coupling yields.
With the exception of PG17 through PG24,
oligonucleotides were puriﬁed by anion-exchange HPLC
(Waters Protein Pak DEAE-5PW column; 7.5
mm 7.5cm), desalted by size-exclusion chromatography
on Sephadex G-25 resin, and characterized by MALDI-
TOF mass spectrometry (Kratos Kompact-III Instrument;
Kratos Analytical Inc., New York). Purity of the
isolated oligonucleotides was 495% by HPLC. PG17–24
were used as obtained following deprotection and
desalting.
UV thermal melting studies (Tm)
UV thermal dissociation data was obtained on a Varian
CARY 1 spectrophotometer equipped with a Peltier
temperature controller. Thrombin-binding aptamers
(PG1–14) were dissolved in Tm buﬀer (10mM Tris,
pH 6.8, with and without 25mM KCl) at a ﬁnal
concentration of 8mM (42). Thrombin-binding aptamers
were annealed in Tm buﬀer at 808C for 10min, allowed to
cool to room temperature and refrigerated (48C) overnight
before measurements. dT2G4T2 and related sequences
(PG17–20) were dissolved in phosphate-buﬀered saline
(PBS buﬀer, pH 7.2) composed of 137mM NaCl, 2.7mM
KCl, 1.5mM KH2PO4, 8mM Na2HPO4 at a ﬁnal
concentration of 20mM (43). The telomeric DNA
dG4T4G4 and related sequences (PG21–24) were dissolved
in 10mM sodium phosphate buﬀer (pH 7, 0.1mM EDTA
and 200mM NaCl) at a ﬁnal concentration of 100mM
(44). All samples (PG17–24) were annealed at 988C for
5min, naturally cooled down to room temperature and
refrigerated (48C) overnight before measurements. The
annealed samples were transferred to pre-chilled
Hellma QS-1.000 (Cat #114) quartz cell, sealed with a
Teﬂon-wrapped stopper and degassed by placing them in
Table 1. Sequences, CD, Tm and binding data of 20F-ANA modiﬁed thrombin-binding aptamers
Code Type Sequence
a Tm (Tm)
b (8C) CD type
c Hysterisis in Tm
d Kd (nM)
e t1/2 (h)
f
PG1 All DNA d(GGTTGGTGTGGTTGG) 46.4
(42) II no 210 0.5
47.4 200
(6)
PG2 All 20F-ANA d(GGTTGGTGTGGTTGG) 54.1 (+0.4) I yes 500 424
PG3 20F-ANA G-anti d(GGTTGGTGTGGTTGG) 53.3 (+1.5) II no 4700 4.8
PG4 20F-ANA G-anti& loop d(GGTTGGTGTGGTTGG) 61.6 (+1.3) II no 500 9.4
PG5 20F-ANA G-syn d(GGTTGGTGTGGTTGG) 45.4 (– 0.5) I yes 4700 0.8
PG6 20F-ANA G-syn&loop d(GGTTGGTGTGGTTGG) 48.5 (+0.1) I yes 4700 0.6
PG7 20F-ANA G-quartet d(GGTTGGTGTGGTTGG) 50.2 (+0.4) I yes 450 4.0
PG8 20F-ANA all-loop d(GGTTGGTGTGGTTGG) 56.3 (+1.3) II no 280 5.9
PG9 20F-ANA loop d(GGTTGGTGTGGTTGG) 57.1 (+1.6) II no 300 2.8
PG10 20F-ANA loop d(GGTTGGTGTGGTTGG) 51.2 (+0.8) II no 250 2.7
PG11 20F-ANA loop d(GGTTGGTGTGGTTGG) 56.6 (+1.8) II no 370 5.1
PG12 20F-ANA loop d(GGTTGGTGTGGTTGG) 59.1 (+2.9) II no 310 3.5
PG13 20F-ANA loop d(GGTTGGTGTGGTTGG) 51.0 (+0.9) II no 58 3.4
PG14 20F-ANA loop d(GGTTGGTGTGGTTGG) 50.6 (+0.8) II no 40 2.0
P8 ssDNA control d(GTCTCTTGTGTGACTCTGGTAAC) NA NA NA NC 0.5
H1 Hairpin control (RNA) r(GGACUUCGGUCC) NA NA NA NC NA
aCapital and bold letter: 20F-ANA.
bTm is the Tm change per each 20F-ANA residue between any modiﬁed aptamer with the unmodiﬁed DNA aptamer (PG1, Tm=47.48C); NA:
not applicable.
c‘Type I’ CD spectrum refers to a positive CD band at  265nm and a negative band at  240nm that correlates with G-anti conformation in the
G-quartet. ‘Type II’ CD refers to a CD spectrum with positive band at  295nm and a negative band at  260nm, which indicates a mixed anti-G
and syn-G conformation in the G-quartet. CD was measured in the buﬀer of 10mM Tris, pH 6.8, 25mM KCl (12).
dHysterisis in Tm refers to the hysterisis existing between a heating and cooling process with 0.58C/min temperature change during Tm measurements.
eKd was roughly estimated from the concentration (nM) where 50% of the maximum binding percentage was observed with a certain aptamer during
the thrombin concentrations studied; NC: not calculated.
fHalf-life in 10% fetal bovine serum (FBS) as monitored by 20% polyacrylamide gel electrophoresis.
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obtained from the following internet site (http://
www.idtdna.com/analyzer/applications/oligoanalyzer)
based on the nearest-neighbor approach (45) and modiﬁed
aptamers (phosphorothioates and 20F-ANA) were
assumed to have the same extinction coeﬃcient as the
natural DNA aptamer. Denaturation/cooling curves were
acquired at either at 295nm for d(G2T2G2TGTG2T2G2)
and related sequences (PG1–14), dG4T4G4 and related
sequences (PG21–24), or at 260nm for dT2G4T2 and
related sequences (PG17–20), at a heating/cooling rate of
0.58C/min between 10 and 808C (for PG1–14), 20 and
908C (for PG17–20) or 40 and 988C (for PG21–24). The
data were analyzed with the software provided by Varian
and converted to Microsoft Excel (Tables 1 and 2). The
decreases in UV absorbance (hypochromicity) with
increasing temperature were normalized between 1 and 0
by the formula: N=(At Al)/(Ah Al), where At is the
absorbance at any given temperature (t), Al is the
minimum absorbance reading at high temperature and
Ah is the maximum absorbance reading at low tempera-
ture. Tm concentration dependence studies were also
conducted in the same way at 295nm using thrombin-
binding aptamers (PG1–14) with diﬀerent concentrations
ranging from 4 to 76mM. Starna quartz cells (Starna Cells,
Inc., Cat. # 1-Q-1) with 1-mm path length were used at
high concentrations to reduce the amount of aptamers
required and to avoid exceeding the Absorbance range of
the instrument.
Circulardichroism (CD) spectra
CD spectra (200–320nm) were collected on a Jasco J-710
spectropolarimeter at a rate of 100nm/min using fused
quartz cells (Hellma, 165-QS). Measurements were carried
out either in 10mM Tris, pH 6.8 (with and without 25mM
KCl) at a concentration of 8mM for thrombin-binding
aptamers (PG1–14) (42); in PBS buﬀer (pH 7.2, 137mM
NaCl, 2.7mM KCl, 1.5mM KH2PO4, 8mM Na2HPO4)
for dT2G4T2 and related sequences (PG17–20) at a ﬁnal
concentrationof20mM(43),orinsodiumphosphatebuﬀer
(10mM sodium phosphate buﬀer, pH 7, 0.1mM EDTA
and 200mM NaCl) for dG4T4G4 and related sequences
(PG21–24) at a ﬁnal concentration of 100mM (44).
Temperature was controlled by an internal circulating
bath (VWR Scientiﬁc) at constant temperature. The data
was processed using J-700 Windows software supplied by
the manufacturer (JASCO, Inc.). To facilitate compari-
sons, the CD spectra were background subtracted,
smoothed and corrected for concentration so that molar
ellipticities could be obtained. Temperature-dependent CD
spectra were also conducted for dT2G4T2 and related
sequences (PG17–20). A 10-min equilibration time was
allowed at each temperature before CD scanning. The Tm
proﬁle was obtained by plotting the maximum molar
ellipticities versus temperature and normalizing.
Nuclease stability assay
Nuclease stability of anti-thrombin aptamers was con-
ducted in 10% fetal bovine serum (FBS, Wisent Inc., Cat.
#080150) diluted with multicell Dulbecco’s Modiﬁed
Eagle’s Medium (DMEM, Wisent Inc., Cat. #319005-
CL) at 378C. A single-strand DNA (ssDNA) 23mer (P-8),
which is unable to form G-quadruplexes, was used as a
control. Approximately 8mmol of stock solution of
aptamers and ssDNA control ( 1.2 O.D.U) was evapo-
rated to dryness under reduced pressure and then
incubated with 300ml 10% FBS at 378C. At 0, 0.25, 0.5,
1, 2, 6 and 24h, 50ml of samples were collected and stored
at –208C for at least 20min. The samples were evaporated
to dryness and then 10ml of gel loading buﬀer and 10mlo f
Table 2. CD and Tm data of d(T2G4T2) and d(G4T4G4) and related oligonucleotides
Code Type Sequence
a CD Type
b,c Tm
d (Tm)
e (8C)
d(T2G4T2) and related sequences
PG17 All PO-DNA PO-d(TTGGGGTT) I 66.0
PG18 All PS-DNA PS-d(TTGGGGTT) I 73.5
(43)
74.0
PG19 All PS-20F-ANA PS-d(TTGGGGTT) I 83.0 (+1.1)
PG20 PS-20F-ANA-G PS-d(TTGGGGTT) I 87.0 (+3.3)
d(G4T4G4) and related sequences
PG21 All PO-DNA PO-d(GGGGTTTTGGGG) II 65
(44)
64.4
PG22 All PO-20F-ANA PO-d(GGGGTTTTGGGG) I 90.0 (+2.1)
PG23 G-syn PO-d(GGGGTTTTGGGG) I 72.5 (+2.0)
PG24 G-anti PO-d(GGGGTTTTGGGG) II 66.2 (+0.5)
aCapital and bold letter: 2’F-ANA; PO: phosphate linkage; PS: phosphorothioate linkage.
bCD type I & II refer to the note in Table 1.
cdT2G4T2 and related sequences (PG17–20): phosphate-buﬀered saline (PBS buﬀer, pH 7.2 at 258C), 137mM NaCl, 2.7mM KCl, 1.5mM KH2PO4,
8mM Na 2HPO4; strand concentration: 20mM for both CD and Tm experiments. dG4T4G4 and related sequences (PG21–24): 10mM sodium
phosphate buﬀer, 0.1mM EDTA, pH 7 and 200mM NaCl; strand concentration: 10mM.
ddT2G4T2 and related sequences (PG17–20): phosphate-buﬀered saline (PBS buﬀer, pH 7.2 at 258C), 137mM NaCl, 2.7mM KCl, 1.5mM KH2PO4,
8mM Na 2HPO4; strand concentration: 20mM; Tm data were generated from concentration-dependent CD spectra (Figure S5 and ‘Materials and
methods’ section). dG4T4G4 and related sequences (PG21–24): 10mM sodium phosphate buﬀer, 0.1mM EDTA, pH 7 and 200mM NaCl; strand
concentration: 100mM; Tm measurements were conducted at 295nm wavelength.
eTm (8C) is the Tm change/20F-ANA modiﬁcation of PG18–20 or PG22–24 relative to the control PG18 (74.08C) or PG21 (PG64.48C), respectively.
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for polyacrylamide gel electrophoresis (PAGE), which was
carried out at room temperature using 20% polyacryla-
mide gel in 0.5  TBE buﬀer (Tris-borate-EDTA).
The degradation patterns on the gels were visualized
using Stains-All (Bio-Rad) according to the manufac-
turer’s protocol.
50-Endlabeling ofsynthetic oligonucleotides
Aptamers (PG1–14) were radiolabeled at the 50-hydroxyl
terminus with a radioactive
32P probe using a T4
polynucleotide kinase (T4 PNK) according to the manu-
facture’s speciﬁcations (MBI Fermentas Life Sciences,
Burlington, ON). Incorporation of the
32P label was
accomplished in reaction mixtures consisting of DNA
aptamers substrate (100pmol), 2ml1 0  reaction buﬀer
(500mM Tris–HCl, pH 7.6 at 258C, 100mM MgCl2,
50mM DTT, 1mM spermidine and 1mM EDTA), 1mlT 4
PNK enzyme solution (10U/1ml in a solution of 20mM
Tris–HCl, pH 7.5, 25mM KCl, 0.1mM EDTA, 2mM
DTT and 50% glycerol), 6ml[ g-
32P]-ATP solution
(6000Ci/mmol, 10mCi/ml; Amersham Biosciences, Inc.)
and autoclaved sterile water to a ﬁnal volume of 20ml.
The reaction mixture was incubated for 30–45min at
378C, followed by a second incubation for 5min at 958C
to thermally denature and deactivate the kinase enzyme.
The solution was puriﬁed according to a standard
protocol (46) and the isolated yield of
32P-50-DNA
following gel extraction averaged 50%. The pure labeled
samples were kept at –208C for future use.
Nitrocellulose filter binding assay
Labeled aptamers (1.25pmol) were heated to 958C for
5mininthebindingbuﬀer(Tris–Ac,pH7.4,140mMNaCl,
5mM KCl, 1mM CaCl2, 1mM MgCl2) (6) and immedi-
ately placed on ice for 5min before binding to increasing
concentrations of thrombin protease (Amersham
Biosciences, Inc.) ranging from 10 to 1000nM in the
binding buﬀer at 378C in a ﬁnal volume of 20ml for
30min.Mixtureswereﬁlteredthroughanitrocelluloseﬁlter
(13mm Millipore, HAWP, 0.45mm) pre-wetted with
binding buﬀer in a Millipore ﬁlter binding apparatus, and
immediately rinsed with 600ml ice-cold washing buﬀer
[Tris–Ac, pH 7.4, 140mM NaCl, 5mM KCl, 1mM CaCl2,
1mM MgCl2, 1% sodium pyrophosphate (w/v)], then the
ﬁlter was air-dried and the bound aptamer quantiﬁed
by scintillation counting. The binding percentage (%) was
calculated by the subtraction of the background from
thecountsinthemicrotube.Kdwasroughlyestimatedfrom
the concentration (nM) where 50% of the maximum
binding percentage was observed with a certain aptamer
during the thrombin concentrations studied.
RESULTS AND DISCUSSION
Oligonucleotide aptamers derived from SELEX have
drawn great attention for their potential as therapeutic
and diagnostic agents (47–50). The application of nucleic
acid aptamers in vivo and their possible use in pharma-
cotherapy face the same key hurdles as siRNA and
antisense based therapeutics, e.g. delivery, cellular uptake
and biostability. To date, several methods have been
devised to improve the stability of aptamers, most of
which make use of SELEX, including a mirror-design of
RNA aptamers (or ‘Spiegelmers’) (51); post-SELEX
modiﬁcation by 20-OMe to increase the stabilization of
RNA aptamers (32); and direct evolution in SELEX using
modiﬁed dNTPs or rNTPs (e.g. 20-F, 20-NH2 pyrimidine
50-triphosphate) (52–56). Macugen, an aptamer recently
approvedbytheFDAforthetreatmentofneovascularage-
related macular degeneration, is a 20F/20-OMe ribose-
modiﬁedoligomer(57).Therestillexistsagreatdemandfor
new methods and more diverse range of chemistries to
create aptamers with more favorable pharmacokinetic
properties.
Afully 20F-ANA modified thrombin-binding aptamer
The study began with the replacement of all the
deoxynucleotides in the thrombin-binding aptamer
d(G2T2G2TGTG2T2G2)b y2 0F-ANA units. Consistent
with literature results (15,42), it was found through
comparisons of the Tm proﬁles both with and without
the presence of K
+, that potassium ions stabilized the
unimolecular G-quadruplex of the DNA aptamer (PG1)
(Figure 2A and B). As shown in the literature, similar
hypochromicity (UV absorbance decrease with increased
temperature) was observed at 295nm for all DNA
sequence (42), which is an indication of G-quartet
formation (12,58). The Tm of the all DNA aptamer
obtained in this study was 47.48C (Table 1 and Figure 2B),
consistent with 46.48C reported by Smirnov and Shafe
(42) and the CD spectra also support the UV melting
experiment. Previous studies have shown two typical CD
spectra: a CD spectrum with a positive CD band at
 265nm and a negative band at  240nm (Type I CD
spectrum) is related to a parallel quadruplex with all
anti-Gs, while one with a positive band at  295nm and
a negative band at  260nm (Type II CD spectrum)
corresponds to antiparallel quadruplex with alternating
syn-anti Gs (12). The all DNA aptamer shows very low
amplitude bands without K
+, whereas it demonstrates
characteristic Type II CD when K
+ is present, indicating
a G-quadruplex structure with alternating syn-anti Gs
(Figure 2C and D) (11,12). The lack of concentration
dependence in the Tm data (Figure 3) and the lack
of hysteresis in the heating/cooling processes (Figure 4)
support a unimolecular G-quadruplex structure
(Figure 1B). Lack of hysteresis at a heating/cooling rate
of 0.58C/min indicates a fast kinetics for the formation of
unimolecular quadruplexes (58).
The all 20F-ANA aptamer (PG2) also forms a deﬁned
G-quadruplex stabilized by K
+ in the UV melting
experiment (Figure 2A and B). The G-quadruplex of all
20F-ANA aptamer (PG2) is more thermally stable than
the all DNA aptamer (PG1) (Tm=0.48C/20F-ANA
modiﬁcation in Table 1). Further characterization experi-
ments indicated that the G-quadruplex PG2 formed in K
+
is diﬀerent from that of that of PG1. The eﬀect of K
+ on
the CD spectra is consistent with the Tm experiment: very
low absorbance in the absence of K
+ and a strong positive
Nucleic Acids Research, 2007, Vol. 35, No. 15 4981absorbance peak at 260nm in the presence of K
+.
Clearly this CD spectrum is Type I, which corresponds
to a parallel quadruplex with all anti-Gs (11,12).
A concentration-dependent Tm proﬁle indicates the
existence of intermolecular G-quadruplex formation
(Figure 3). Even though we could not tell the existence
of a dimeric or tetrameric G-quadruplex with all parallel
strand alignments, it is clearly shown that all 20F-ANA
aptamer (PG2) could not maintain the unimolecular
G-quadruplex topology (Figure 1B). An intermolecular
G-quadruplex is thus formed to support a G-quartet
structure with all anti-Gs. Hysteresis was observed in the
heating and cooling processes, again supporting an
intermolecular G-quadruplex adopted by PG2 (Figure 4).
Replacement of anti-Gs andsyn-Gs with20F-ANA
Nucleotides with preferred glycosidic conformations have
been utilized to investigate their eﬀect on the topology
and molecularity of G-tetrads. For example, 8-methyl-
deoxyguanosine (8-Me-dG) and 8-bromodeoxyguanosine
(8-Br-dG) which prefer syn conformation have demon-
strated to play an important role in G-quadruplex
conformation and thermal stability when they are used
to modify a tetrameric G-quadruplex [d(TGGGT)]4
(59,60). Recent studies by Tang and Shafer (61) demon-
strate that ribonucleic acids which favor an anti con-
formation provide enough driving force to change
the topology and molecularity for the thrombin-binding
aptamer d(G2T2G2TGTG2T2G2). A single locked nucleic
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Figure 2. Tm proﬁles of selected 20F-ANA-modiﬁed thrombin-binding aptamers (Table 1) measured at 295nm in buﬀer 10mM Tris, pH 6.8 (A)
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folded quadruplex d(G4(T4G4)3) has also been shown to
induce a signiﬁcant topological change to a parallel
quadruplex in the presence of K
+ (62). 20F-ANA unit
which has been shown to have a conformationally biased
sugar pucker (33) (i.e. more south/east than its DNA
counterpart), is expected to favor an anti conformation in
order to avoid steric interaction between guanine and the
b-face ﬂuorine (63) (Figure 5). Therefore, the next phase
of the investigation was to study the eﬀect of 20F-araG
on anti-Gs and syn-Gs observed in the diﬀerent
G-quadruplexes discussed earlier (see ‘Introduction’ sec-
tion). We expected that the replacement of anti-Gs with
20F-ANA would lead to thermal stabilization since
preorganization of the anti glycosidic conformation
favored by 20F-araG (63) would reduce the loss of entropy
during G-quartet assembly. Conversely, replacement of
syn-Gs with 20F-araGs is expected to cause destabilization
or complete disruption of the G-quartet structure
altogether.
The obtained Tm and CD data are consistent with the
expected results. Modifying the anti-Gs with 20F-ANA
(PG3) or modifying both the anti-Gs and the loops with
20F-ANA (PG4) increases thermal stability in the presence
of K
+ (Tm=+1.3–1.58C/20F-ANA modiﬁcation).
The CD spectrum of PG3 was Type I CD, similar to the
all DNA aptamer (PG1) (Figure 2C and D). Remarkably,
PG4 shows a clear Type I CD both without and with K
+,
demonstrating that the G-quadruplex adopted by PG4
could form even in the absence of K
+. In addition, it
suggests that replacement of the loop with 20F-ANA
further beneﬁts the G-quadruplex formation. This is
consistent with previous work showing that all the
thymidines in this thrombin-binding DNA aptamer
adopt the anti orientation (15). A concentration-
independent Tm proﬁle (Figure 3) and lack of hysteresis
in heating/cooling processes both support a unimolecular
G-quadruplex structure like the DNA control (Figure 4
and Figure S1 in Supplementary Data). Replacement of
anti-G with 20F-ANA is therefore able to stabilize the
G-quartet without changing the quadruplex topology.
The results of replacement of the syn-Gs with 20F-ANA
also match expectations. Modiﬁcation of the syn-Gs with
20F-ANA (PG5) and replacement of both syn-Gs and
loops (PG6) with 20F-ANA result in less stable complexes
compared with PG3 and PG4. PG5 is even less stable than
the original all DNA aptamer (Tm=–0.58C/20F-ANA
modiﬁcation, Table 1), and PG6 is only as stable as the all
DNA aptamer control (Tm=+0.18C/20F-ANA mod-
iﬁcation, Table 1). CD experiments show that both PG5
and PG6 display very low amplitude peaks at 260nm even
in the presence of K
+, indicating little structure formed
(Figure 2C and D and Figure S4 in Supplementary Data).
A Tm versus concentration study suggested that the Tm of
PG5 and PG6 is independent of concentration so they
likely still form unimolecular structures (Figure 3) but the
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Figure 4. Heating and cooling Tm transitions of 20F-ANA modiﬁed thrombin-binding aptamers (Table 1) measured at 295nm in a buﬀer of 10mM
Tris, 25mM KCl, pH 6.8, at a ﬁnal strand concentration of 8 mM in a heating/cooling rate of 0.58C/min (red ﬁlled square: heating; blue empty
square: cooling).
Figure 5. Glycosic conformation equilibrium of dG and 20F-araG with
south furanose sugar ring.
Nucleic Acids Research, 2007, Vol. 35, No. 15 4983formation of these structures seems kinetically slow based
on the ﬁnding that major hysteresis is observed at a
heating/cooling rate of 0.58C/min (Figure 4 and Figure S1
in Supplementary Data). Taken together, if the uni-
molecular G-quadruplex is maintained in PG5 and PG6,
the folding topology should be changed to tolerate a
unimolecular all-parallel G-quadruplex structure with all
anti-Gs indicated by a Type I CD proﬁle. A parallel
unimolecular quadruplex has been demonstrated in an
X-ray crystal structure of the human telomere sequence
d(AG3(TTAG3)3) by Neidle and coworkers (64) and in a
LNA modiﬁed d(G4(T4G4)3) quadruplex by Dominick
and Jarstfer (62). It seems that this atypical folding in PG5
and PG6 is not favored since the deﬁned structure is not
present in signiﬁcant quantity in solution, as indicated by
the previous CD experiments. The possible reason could
be the loop size and sequences which are important factors
in determining the folding topology (64). Furthermore, in
the case where 20F-araGs replace both syn-Gs and anti-Gs
in the quartet (PG7), we found that 20F-ANA brings
minimal stabilization (Tm=+0.48C/20F-ANA modiﬁ-
cation, Table 1). Type I CD proﬁle (i.e. a positive CD
band at  260nm and a negative band at  240nm) was
observed in the presence of K
+ and not shown in the
absence of K
+, indicating a parallel quadruplex with all
anti-Gs (12), as in PG2. Concentration-dependent Tm
(Figure 3) and signiﬁcant hysteresis observed in heating/
cooling processes (Figure 4) support the idea that PG7
could adopt an intermolecular parallel G-quadruplex with
all anti-Gs. Further non-denaturing shift gel analysis
experiments are needed to conﬁrm the molecularity of
intermolecular G-quadruplexes studied here.
To verify whether anti-Gs can be stabilized by 20F-ANA
in other types of G-quadruplexes, we chose two other
aptamers from the literature.
(A) Anti-HIV phosphorothioate PS-d(T2G4T2) modiﬁed
with 20F-ANA. Both the phosphodiester sequence
PO-d(T2G4T2) and the phosphorothioate sequence
PS-d(T2G4T2) are known to adopt a structure in which
all G residues are in the anti conformation (7,43). As
a result, this aptamer has a characteristic ‘Type I’ CD
signature (Table 2 and Figure 6A) (12). Thermal
denaturation studies at 260nm yielded noisy curves. The
reason for this could be the slow dissociation process of
both phosphodiester and phosphorothioate as reported in
the literature (43). Tm proﬁles shown in Figure 6B were
obtained by plotting the maximum molar ellipticities
versus temperature based on temperature-dependent CD
spectra (Figure S5, Supplementary Data). Although it is
impossible to get accurate Tm data for these kinetically
slow G-quadruplexes, clearly our apparent Tm data help
to conﬁrm the signiﬁcant thermal stabilization provided
by the 20F-ANA-G units (PG18–20, Table 2). Our results
indicate that phosphorothioate modiﬁcations lead to
stabilization, inconsistent with the literature ﬁnding (31).
Compared with the controls PG17 (PO-DNA) and PG18
(PS-DNA), 20F-ANA modiﬁed sequences PG19 and PG20
show large increases in molar ellipticities, indicating a
better guanine–guanine interactions within the G-quartet
structure.
(B) A telomeric DNA d(G4T4G4) modiﬁed with
20F-ANA. Structural analysis has shown that a telomeric
DNA sequence d(G4T4G4) (PG21, Table 2) can form a
symmetrical dimeric quadruplex with four G-quartets and
a diagonal loop in the presence of Na
+ (Figure 1C)
(21,22). The guanine conformation is 50-d(GsGaGsGa-
TTTT-GsGaGsGa)-30 where s denotes syn and a anti
(22,25). Several sequences, including a fully 20F-ANA
modiﬁed sequence (PG22), a sequence with 20F-ANA
replacing all syn-Gs (PG23) and a sequence with 20F-
ANA modiﬁcations for all anti-Gs (PG24), were tested
(Table 2). When the anti-G residues were replaced by 20F-
ANA G residues, a modest thermal stabilization of the
G-quadruplex structure resulted, without disruption of the
3D structure (Table 2, and Figure 7A and B). When
the syn-G residues were replaced (PG22 and PG23),
a remarkable increase in thermal stabilization of the
G-quadruplex structure resulted (up to 258C; Table 2),
with a concomitant Type II-to-Type I conformational
change induced by the 20F-ANA-G(anti) replacement
(Figure 7A).
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4984 Nucleic Acids Research, 2007, Vol. 35, No. 15Overall, these two additional examples conﬁrm the
results obtained for the thrombin-binding aptamers: the
modiﬁcation of anti-Gs with 20F-ANA can generally
stabilize a G-quartet requiring anti-Gs, maintaining the
overall quadruplex conformation, while the modiﬁcation
of syn-Gs with 20F-ANA is not favored and results in
a complete conformational switch to an alternative
G-quadruplex structure, as indicated by the change of
CD type from II to I for PG2, PG5, PG6, PG7, PG22 and
PG23 (Tables 1 and 2, Figure 2D, Figure 7A and
Figure S4 in Supplementary Data). The stabilizing eﬀects
of 20F-ANA on G-quadruplexes is related to the
conformational preorganization and the small steric
eﬀect of the ﬂuorine atom. 20-O-Methyl modiﬁcation
generates steric problems at the 20 position and is often
shown to destabilize a unimolecular G-quadruplex,
resulting in signiﬁcant conformational perturbation in
both intra- and intermolecular G-quadruplex systems (31).
The ability to switch G-quartet structures with a
b-ﬂuorine atom may be exploited to enrich the population
of one of several interconverting G-quadruplex conforma-
tions (a b-ﬂuorine ‘‘switch’’).
Replacement of loops with20F-ANA
Thymine bases in the loop region of the thrombin-binding
aptamer d(G1G2T3T4G5G6T7G8T9G10G11T12T13G14G15)
(Figure 1B) exclusively prefers the anti orientation (15).
The literature reports that G8 shows base stacking
interactions with the ﬁrst G-quartet but the conformation
of the nucleotide was not mentioned (18). The replacement
of G8 with 20F-araG in this study resulted in an increase of
0.88Ci nTm (PG8 and PG9 in Table 1). It was expected
that the replacement of anti thymines in the loops with
anti conformationally biased 20F-araT should increase
thermal stability. Thermal melting studies support this
hypothesis (PG8–14, Table 1). Diﬀerent positions of
thymidine contribute to the stability of the G-quadruplex
to diﬀerent degrees (Table 1 and Figure S2,
Supplementary Data). 20F-ANA replacements in the
loops consisting of two thymidines (PG12) bring a
greater thermal stabilization (Tm=2.98C/20F-ANA
modiﬁcation, Table 1) than with modiﬁcation in the
TGT loop (PG9, Tm=1.68C/20F-ANA modiﬁcation,
Table 1). T3 and T12 are the most sensitive positions to
20F-araT modiﬁcation resulting in an almost 68C diﬀer-
ence in Tm (PG9 versus PG10; PG11 versus PG14,
Table 2), while the replacement of T13 and T4 with 20F-
araT is much less sensitive and results only in slight Tm
increases of 18C (PG9 versus PG11, Table 2) and 0.28C
(PG10 versus PG13, Table 2), respectively. The crystal
structure of this DNA aptamer bound to thrombin
suggests that T3 and T12 are diﬀerent from T4 and T13.
It appears that the bases of T3 and T12 do not interact with
any other moieties within the aptamer, nor do they
interact with thrombin, instead, they extend out into the
solvent (18). Modifying T3 and T12 with 20F-araT might
change the conformation of the loops, bringing out
stabilization to the whole G-quadruplex structure as
suggested by the Tm increase. A detailed picture, however,
is diﬃcult to describe at this stage. The replacement of the
central nucleotide G8 with a 20F-araG is also less
important for stabilization (PG8 versus PG9, only 0.88C
Tm diﬀerence). Overall, 20F-ANA modiﬁcations of loop
deoxynucleotides stabilizes the formation of a unimole-
cular G-quadruplex (Figure 1B), as supported by all CD
and UV melting analysis. It was found that all loop-
modiﬁed thrombin-binding aptamers (PG8–14) maintain
Type II CD in the presence of K
+, like the DNA aptamer
control (Figure S4, Supplementary Data). Remarkably, in
the absence of K
+, a relatively strong positive peak at
 295nm is still observed, which indicates signiﬁcant
G-quartet formation. Therefore, replacement of the loop
deoxynucleotides with 20F-ANA signiﬁcantly helps with
the formation of G-quadruplex structure. They show
concentration-independent Tm data, indicating a uni-
molecular structure, in agreement with a lack of hysteresis
in heating/cooling processes (Figure 4 and Figure S1,
Supplementary Data).
Nuclease resistance induced by 20F-ANA
Incorporation of 20F-ANA in oligonucleotides leads to
an improvement in nuclease resistance (34). This study
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modiﬁed thrombin-binding aptamers (PG1–14, Table 1).
The data clearly shows that 20F-ANA modiﬁed aptamers
have enhanced half-lives in 10% FBS (in some cases
448-fold compared with PG1, Figure S6 in Supplementary
Data and Table 1) but nuclease stability is found to be
dependent on both the position (esp. syn-G and anti-G)
and number of 20F-ANA residues within the oligonucleo-
tide backbone. For example, replacing anti-Gs with
20F-ANA (PG3 and PG4) increases the half-lives to 4.8
and 9.4h, respectively, while replacing syn-Gs with
20F-ANA (PG5 and PG6) does not yield much gain in
biostability with half-life increases of only 0.8 and 0.6h,
respectively, comparable to the DNA aptamer (PG1)
(Figure S6 in Supplementary Data and Table 1). These
diﬀerences could be justiﬁed by the previous ﬁnding that
PG5 and PG6 only form insigniﬁcant G-quadruplex
structures (Figure 2D) due to the unfavored conformation
of the perturbed syn-Gs. It is expected that a complex
structure should be less accessible for nuclease attack
compared to dissociated or ‘open’ oligonucleotides.
Furthermore, the nuclease stability of PG13 and PG14 is
enhanced over PG1 by a factor of 4–7 with only four
20F-ANA incorporated (Table 1). Modiﬁcation of the
loop residues of stable structures (e.g. PG4, PG8) may
have a double eﬀect since the increased stability of
the duplex would be combined with protection of the
nucleotides most exposed to endonuclease attack.
Binding affinityof 20F-ANA-modified thrombin-binding
aptamers withthrombin
As mentioned in the ‘Introduction’ section, the structure
of the thrombin-binding aptamer is very sensitive to
chemical modiﬁcations, which often undermine its
thermal stability and/or binding activity (31). Thus, a
ﬁnal experiment in this study was conducted using
nitrocellulose ﬁlter binding assays to assess the eﬀect of
20F-ANA modiﬁcations on the thrombin binding aﬃnity.
Data are presented in Table 1 and in Figure 8. ssDNA
(P8) and hairpin (H1) controls show no binding to
thrombin as expected (18). Binding of 20F-ANA aptamers
to thrombin is always adversely aﬀected by 20F-ANA
modiﬁcations on G-quartets themselves, whether syn-o r
anti-Gs are modiﬁed (PG2-PG6). Some loop modiﬁca-
tions with 20F-ANA also disfavor thrombin binding
(PG8–PG12). However, two loop-modiﬁed aptamers
(PG13 and PG14, Table 1) show a 4–5-fold enhancement
in thrombin-binding aﬃnity. This conclusion should bear
in mind that while these two aptamers may have enhanced
binding aﬃnity, the slope of the concentration response is
not as sharp as that for the native PG1. Therefore, this
study reveals the ﬁrst 20F-ANA modiﬁed thrombin-
binding aptamers to combine enhanced thermal and
nuclease stability with apparently slightly stronger binding
aﬃnity. Previous structural studies by NMR and crystal-
lography suggest that the loop moieties would change
conformation during binding to thrombin (18). The TGT
loop is involved with the ﬁbrinogen exosite and two TT
loops could interact with the heparin exosite. It seems
therefore that two 20F-ANA-T residues when present in
one of the TT loops and the TGT loop enhance thrombin
binding.
CONCLUSIONS
In the present study 20F-ANA modiﬁed oligonucleotides
were investigated based on a thrombin-binding DNA
aptamer d(G2T2G2TGTG2T2G2), an anti-HIV phos-
phothioate PS-d(T2G4T2) and a DNA telomeric sequence
d(G4T4G4) (Tables 1 and 2) by UV thermal denaturation
and CD experiments. Generally, replacement of anti-Gs
with 20F-ANA can stabilize a G-quartet requiring anti-Gs
and maintain the quadruplex conformation, while repla-
cement of syn-Gs with 20F-ANA is not favored and
results in complete conformational change of the
G-quadruplexes. The data shows that appropriate incor-
poration of 20F-ANA residues into G-quadruplexes leads
to an increase in the melting temperature of the complex
formed (Tm up to  +38C/20F-ANA modiﬁcation,
Tables 1 and 2). The structure of thrombin-binding
aptamers is stabilized by the presence of potassium ions.
Nuclease resistance of 20F-ANA modiﬁed thrombin-
binding aptamers is increased up to 48-fold in 10% FBS.
Two 20F-ANA-modiﬁed thrombin-binding aptamers
(PG13 and PG14) show a 4–5-fold enhancement in
binding aﬃnity to thrombin along with increased thermal
stability and nuclease resistance. Therefore, the impact of
20F-ANA modiﬁcations on G-quartets and loop regions
has been demonstrated. The study suggests that 20F-ANA
may positively impact oligonucleotide-based therapeutics
involving G-quadruplexes.
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